WisdomTree Bloomberg U.S. Dollar Bullish Fund (ARCA: USDU)

에 대한 최신 뉴스 WisdomTree Bloomberg U.S. Dollar Bullish Fund (ARCA:USDU)

Other

Financial Services

The fund is an actively managed ETF that seeks to provide total returns, before fees and expenses, that exceed the performance of the index. The index is structured to potentially benefit as the U.S. dollar appreciates relative to a basket of global currencies. The fund will seek exposure to both the U.S. dollar and global currencies held by the index through investing, under normal circumstances, at least 80 percent of its assets in money market securities and other liquid securities. It is non-diversified.

Wisdomtree Floating Rate Tre

WisdomTree Bloomberg US Dollar Bullish Fund

Chase Freedom Unlimited®

Currency ETFs

ETFs

GOOGL

HEFA

USDU

PowerShares DB US Dollar Index Bullish Fund

미국 달러의 추세는 강세를 보이고 있지만 Invesco DB US Dollar Index Bullish Fund (NYSE:UUP)는 올해 들어 약 0.8% 하락했다. 여러 지표들이 달러가 단기적으로도 회복세를 유지할 수 있음을 시사하고 있으며, 이 추세로 혜택을 받을 수 있는 여러 ETF들이 있다:

그린백에 베팅하기: 달러 궤적은 여전히 강하며, 이 ETF들이 큰 승리를 거둘 것으로 전망

New,York,-,May,22:,New,York,Stock,Exchange,May

Analyst Color

Equities

News

Markets

AVGO

AXON

SPDR Dow Jones Industrial Average ETF Trust

NVDA

Fidelity NASDAQmposite Index Fund ETF-Tracking NASDAQmposite Index

ONEQ

PLTR

RSPF

TRGP

XLRE

2024년은 이정표를 세운 한 해였다. 현재의 강세장은 거의 26개월이 지났지만 흔들림 없는 상승세를 보이고 있다. 이는 2022년 10월 중순의 저점 대비 70% 이상 상승한 수치다. 한 해를 마무리하며 &#39;산타 랠리&#39;의 가능성을 염두에 두고 2024년의 중요한 시점을 정리해 보려고 한다.

2024년 S&amp;P 500 지수는 57회 사상 최고치 경신, 나스닥 급등의 30%는 &#39;매그 7&#39; 그룹이 주도

Impact Of A Weaker Currency

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

목요일 미국 주식시장 뉴스 요약: 11월 21일 목요일, 미국 시장이 상승 마감했다. 다우지수가 461포인트 상승했으며, S&amp;P 500이 32포인트 추가 상승, 나스닥이 6포인트 소폭 상승했다. 세일즈포스는 견고한 실적으로 다우를 이끌었고, 엔비디아는 성장 전망이 완화되었음에도 불구하고 강력한 실적으로 상승했다. 반면, 알파벳은 법무부의 반독점 압박에 따른 급락을 경험했다.

미국이 잠든 사이 아시아는 혼조, 유럽은 대부분 하락; 달러는 13개월 만에 최고치

WisdomTree Bloomberg U.S. Dollar Bullish Fund

Axis Capital Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXS#NYSE">AXS</a>) has outperformed the market over the past 5 years by 7.43% on an annualized basis producing an average annual return of 20.59%. Currently, Axis Capital Holdings has a market capitalization of $8.23 billion. 
Buying $100 In AXS: If an investor had bought $100 of AXS stock 5 years ago, it would be worth $261.75 today based on a price of $104.70 for AXS at the time of writing.
<h3>Axis Capital Holdings's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748899826_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Axis Capital Holdings 5 Years Ago Would Be Worth This Much Today

Bridgford Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRID#NASDAQ">BRID</a>) reported quarterly losses of $(0.43) per share. This is a 79.17 percent decrease over losses of $(0.24) per share from the same period last year. The company reported $50.64 million in sales this quarter. This is a 7.03 percent increase over sales of $47.31 million the same period last year.

Earnings

BRID

Bridgford Foods Q2 EPS $(0.43) Down From $(0.24) YoY, Sales $50.64M Up From $47.31M YoY

Management

CUBI

Customers Bancorp Executive Vice President, Chief Financial Officer Philip Watkins To Transition To EVP, Head Of Corporate Development; Mark McCollom Appointed EVP, CFO Effective On Or Around August 15,2025

General

Northern Dynasty Minerals Received Payment Of $12M Representing The Third Tranche Investment Under The Co's Royalty Agreement Dated July 26, 2022

Canadian Pacific Kansas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>) has outperformed the market over the past 20 years by 4.85% on an annualized basis producing an average annual return of 13.14%. Currently, Canadian Pacific Kansas has a market capitalization of $75.98 billion. 
Buying $100 In CP: If an investor had bought $100 of CP stock 20 years ago, it would be worth $1,153.20 today based on a price of $81.37 for CP at the time of writing.
<h3>Canadian Pacific Kansas's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748898919_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Canadian Pacific Kansas 20 Years Ago Would Be Worth Today

Tucows Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCX#NASDAQ">TCX</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TC#TSX">TC</a>) today announced the appointment of Laurenz Nienaber as Chair of the Board of Directors and Jeffrey Tory as Independent Vice Chair, following the election of a new and returning slate of directors at the company's Annual General Meeting on May 20, 2025. In its first meetings, held in the days following the AGM, the newly constituted Board established its committee leadership and governance structure, reaffirming its commitment to proactive oversight and long-term value creation for Tucows shareholders.

TSX:TC

Tucows Announces The Appointment Of Laurenz Nienaber As Chair Of The Board Of Directors

Offerings

Pembina Pipeline To Issue $200M Aggregate Principal Amount Of 5.95% Fixed-To-Fixed Rate Subordinated Notes, Series 2  Due June 6, 2055

<h3>Gainers</h3>
<ul>
<li>Mixed Martial Arts Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) stock rose 9.9% to $0.95 during Monday's after-market session. The company's market cap stands at $9.9 million. </li>
<li>LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) shares increased by 7.16% to $4.04. The company's market cap stands at $822.4 million. </li>
<li>Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) stock rose 6.69% to $1.1. The market value of their outstanding shares is at $15.1 million. </li>
<li>Nerdy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRDY#NYSE">NRDY</a>) shares rose 4.76% to $1.75. The company's market cap stands at $209.5 million. </li>
<li>United Homes Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UHG#NASDAQ">UHG</a>) stock moved upwards by 4.68% to $3.8. The market value of their outstanding shares is at $222.6 million. </li>
<li>QVC Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QVCGA#NASDAQ">QVCGA</a>) shares increased by 4.51% to $3.7. The company's market cap stands at $29.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ECD Automotive Design (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECDA#NASDAQ">ECDA</a>) shares decreased by 13.0% to $0.3 during Monday's after-market session. The company's market cap stands at $10.4 million. </li>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) shares decreased by 7.4% to $2.63. The market value of their outstanding shares is at $12.0 million. </li>
<li>China Liberal Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) stock declined by 6.97% to $0.95. The market value of their outstanding shares is at $255.5 million. </li>
<li>Allied Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGAE#NASDAQ">AGAE</a>) shares declined by 6.95% to $2.41. The company's market cap stands at $106.2 million. </li>
<li>Fly-E Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) shares decreased by 6.9% to $0.53. The company's market cap stands at $13.0 million. </li>
<li>Lazydays Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) stock declined by 5.83% to $0.26. The company's market cap stands at $29.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AGAE

AMST

CLEU

ECDA

FLYE

GORV

LVWR

NAAS

NRDY

QVCGA

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Theriva Biologics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#AMEX">TOVX</a>) stock moved upwards by 47.4% to $0.72 during Monday's after-market session. The market value of their outstanding shares is at $5.8 million. </li>
<li>MoonLake (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) shares moved upwards by 15.95% to $47.75. The company's market cap stands at $3.0 billion. </li>
<li>FibroGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) shares rose 8.91% to $0.32. The company's market cap stands at $32.3 million. </li>
<li>Owlet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OWLT#NYSE">OWLT</a>) stock rose 8.19% to $6.6. The company's market cap stands at $109.0 million. </li>
<li>Instil Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIL#NASDAQ">TIL</a>) shares moved upwards by 7.92% to $32.0. The market value of their outstanding shares is at $209.9 million. </li>
<li>Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) shares rose 7.27% to $0.51. The company's market cap stands at $10.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ModivCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>) stock fell 22.7% to $1.7 during Monday's after-market session. The market value of their outstanding shares is at $24.4 million. </li>
<li>Adlai Nortye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANL#NASDAQ">ANL</a>) shares fell 17.82% to $1.43. The company's market cap stands at $52.7 million. </li>
<li>Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) stock declined by 16.29% to $4.1. The market value of their outstanding shares is at $36.8 million. </li>
<li>Rapport Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPP#NASDAQ">RAPP</a>) shares decreased by 7.65% to $8.7. The company's market cap stands at $317.5 million. </li>
<li>Unicycive Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNCY#NASDAQ">UNCY</a>) stock decreased by 7.1% to $0.62. The market value of their outstanding shares is at $74.2 million. </li>
<li>Baird Medical Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDMD#NASDAQ">BDMD</a>) stock fell 7.03% to $4.1. The market value of their outstanding shares is at $151.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BDMD

CLNN

FGEN

MLTX

MODV

OWLT

RAPP

TLPH

TOVX

UNCY

12 Health Care Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Rain Enhancement (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAIN#NASDAQ">RAIN</a>) shares increased by 7.9% to $3.4 during Monday's after-market session. The market value of their outstanding shares is at $25.7 million. </li>
<li>Intelligent Living (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) stock rose 6.47% to $0.42. The market value of their outstanding shares is at $7.5 million. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) shares rose 5.15% to $0.58. The company's market cap stands at $83.3 million. </li>
<li>Aqua Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQMS#NASDAQ">AQMS</a>) shares increased by 5.0% to $0.83. The market value of their outstanding shares is at $7.3 million. </li>
<li>Galaxy Payroll Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXG#NASDAQ">GLXG</a>) shares rose 4.99% to $0.57. The market value of their outstanding shares is at $10.2 million. </li>
<li>FTAI Infrastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIP#NASDAQ">FIP</a>) shares rose 4.71% to $6.11. The company's market cap stands at $701.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CleanCore Solutions (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZONE#AMEX">ZONE</a>) shares fell 17.9% to $2.38 during Monday's after-market session. The company's market cap stands at $18.9 million. </li>
<li>Webus International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETO#NASDAQ">WETO</a>) stock decreased by 7.95% to $2.55. The company's market cap stands at $56.0 million. </li>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) stock decreased by 7.9% to $1.4. The company's market cap stands at $112.3 million. </li>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) stock fell 6.49% to $1.73. The company's market cap stands at $19.0 million. </li>
<li>TOMI Environmental Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOMZ#NASDAQ">TOMZ</a>) stock decreased by 6.25% to $1.05. The market value of their outstanding shares is at $21.0 million. </li>
<li>WF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WXM#NASDAQ">WXM</a>) shares decreased by 4.83% to $2.41. The market value of their outstanding shares is at $16.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AQMS

GLXG

HKPD

ILAG

RAIN

SCWO

SPWR

TOMZ

WETO

ZONE

12 Industrials Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Credo Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) stock rose 12.0% to $70.35 during Monday's after-market session. The market value of their outstanding shares is at $11.7 billion. As per the press release, Q4 earnings came out today. </li>
<li>Mercurity Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) shares rose 5.88% to $3.42. The market value of their outstanding shares is at $217.8 million. </li>
<li>Diginex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) shares increased by 5.59% to $47.95. The market value of their outstanding shares is at $1.1 billion. </li>
<li>MultiSensor AI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSAI#NASDAQ">MSAI</a>) shares rose 5.14% to $0.85. The company's market cap stands at $28.4 million. </li>
<li>Arteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIP#NASDAQ">AIP</a>) shares increased by 5.09% to $8.04. The market value of their outstanding shares is at $337.5 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock moved upwards by 4.73% to $0.67. The company's market cap stands at $4.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>SmartKem (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTK#NASDAQ">SMTK</a>) stock declined by 10.4% to $1.29 during Monday's after-market session. The company's market cap stands at $5.7 million. </li>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares fell 8.58% to $0.45. The company's market cap stands at $18.5 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares fell 7.6% to $3.04. The market value of their outstanding shares is at $4.6 million. </li>
<li>Duos Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOT#NASDAQ">DUOT</a>) stock decreased by 5.67% to $7.5. The company's market cap stands at $87.4 million. </li>
<li>Crexendo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXDO#NASDAQ">CXDO</a>) stock fell 5.15% to $5.06. The company's market cap stands at $146.7 million. </li>
<li>Oblong (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBLG#NASDAQ">OBLG</a>) shares decreased by 4.9% to $3.5. The market value of their outstanding shares is at $4.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BNAI

CRDO

CXDO

DGNX

DUOT

MOVE

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

OBLG

SMTK

SOBR

12 Information Technology Stocks Moving In Monday's After-Market Session

RPM Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for RPM Intl, revealing an average target of $117.0, a high estimate of $135.00, and a low estimate of $110.00. This current average represents a 9.8% decrease from the previous average price target of $129.71. 
<img src="https://www.benzinga.com/files/images/story/2025/1748898099_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive RPM Intl is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Buy</td>
<td>$135.00</td>
<td>-</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$110.00</td>
<td>$113.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$116.00</td>
<td>$126.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$116.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Frank Mitsch</td>
<td>Fermium Research</td>
<td>Lowers</td>
<td>Hold</td>
<td>$110.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Vincent Sinisi</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$113.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$126.00</td>
<td>$154.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$110.00</td>
<td>$125.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to RPM Intl. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of RPM Intl compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for RPM Intl's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of RPM Intl's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/RPM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on RPM Intl analyst ratings.</a>
<h2>Get to Know RPM Intl Better</h2>
RPM International Inc manufactures and sells a variety of paints, coatings, and adhesives. The firm organizes itself into four segments based on product type. The construction products group sells coatings, roofing, insulation, and other products to distributors, contractors, and end consumers globally. The performance coatings group produces coatings that are used in construction and industrial applications like floorings and corrosion control. The consumer group sells paint, finishes, and similar products to individual consumers through hardware and craft stores. The specialty products group sells a line of products ranging from niche applications of the other groups to marine finishes, to edible food colorings. The majority of revenue comes from North America.
<h3>RPM Intl's Financial Performance</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Challenges: RPM Intl's revenue growth over 3M faced difficulties. As of 28 February, 2025, the company experienced a decline of approximately -3.05%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: RPM Intl's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.51% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): RPM Intl's ROE excels beyond industry benchmarks, reaching 1.92%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): RPM Intl's ROA excels beyond industry benchmarks, reaching 0.78%. This signifies efficient management of assets and strong financial health.
Debt Management: RPM Intl's debt-to-equity ratio is below the industry average. With a ratio of 0.9, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Expert Outlook: RPM Intl Through The Eyes Of 8 Analysts

In the last three months, 8 analysts have published ratings on Gaming and Leisure Props (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLPI#NASDAQ">GLPI</a>), offering a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $53.0, a high estimate of $60.00, and a low estimate of $48.00. A 0.23% drop is evident in the current average compared to the previous average price target of $53.12. 
<img src="https://www.benzinga.com/files/images/story/2025/1748898090_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of Gaming and Leisure Props's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Kilichowski</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$49.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Greg McGinniss</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$48.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Brad Heffern</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$54.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Chad Beynon</td>
<td>Macquarie</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$60.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$54.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Haendel St. Juste</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$53.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Mitch Germain</td>
<td>Citizens Capital Markets</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>John Kilichowski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$51.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Gaming and Leisure Props. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Gaming and Leisure Props compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Gaming and Leisure Props's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Gaming and Leisure Props's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/GLPI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Gaming and Leisure Props analyst ratings.</a>
<h2>Delving into Gaming and Leisure Props's Background</h2>
Gaming and Leisure Properties Inc, or GLP, is a self-administered and self-managed Pennsylvania real estate investment trust (REIT). It is engaged in acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. Its portfolio consists of gaming and related facilities and amenities such as Ameristar Black Hawk, Bally's Casino, Argosy Casino Alton, Bally's Chicago, Hollywood Casino Aurora, and others located across different states in the United States.
<h3>Financial Milestones: Gaming and Leisure Props's Journey</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Over the 3M period, Gaming and Leisure Props showcased positive performance, achieving a revenue growth rate of 5.13% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 41.76%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Gaming and Leisure Props's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.89% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Gaming and Leisure Props's ROA excels beyond industry benchmarks, reaching 1.3%. This signifies efficient management of assets and strong financial health.
Debt Management: Gaming and Leisure Props's debt-to-equity ratio is below the industry average. With a ratio of 1.71, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GLPI

Breaking Down Gaming and Leisure Props: 8 Analysts Share Their Views

12 analysts have expressed a variety of opinions on Doximity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $61.42, a high estimate of $80.00, and a low estimate of $50.00. A 17.0% drop is evident in the current average compared to the previous average price target of $74.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1748898081_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Doximity among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Larsen</td>
<td>BTIG</td>
<td>Maintains</td>
<td>Buy</td>
<td>$80.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Anne Samuel</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>David Roman</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Vikram Kesavabhotla</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$65.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Steven Valiquette</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Jailendra Singh</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$52.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Brian Peterson</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$65.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Richard Close</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$50.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Scott Berg</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$67.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Ricky Goldwasser</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$60.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Scott Schoenhaus</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Jailendra Singh</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$58.00</td>
<td>$65.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Doximity. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Doximity compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Doximity's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/DOCS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Doximity analyst ratings.</a>
<h2>Get to Know Doximity Better</h2>
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
<h3>Doximity's Economic Impact: An Analysis</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining Doximity's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 17.14% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Doximity's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 45.17%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Doximity's ROE stands out, surpassing industry averages. With an impressive ROE of 5.91%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Doximity's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.13% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DOCS

Doximity Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)

Ratings for NetApp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>) were provided by 11 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $107.18, a high estimate of $117.00, and a low estimate of $90.00. A 5.07% drop is evident in the current average compared to the previous average price target of $112.91. 
<img src="https://www.benzinga.com/files/images/story/2025/1748898041_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of NetApp's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Asiya Merchant</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$110.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Tim Long</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$117.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$115.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>David Vogt</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$108.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Aaron Rakers</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$100.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$106.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Asiya Merchant</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$105.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Tim Long</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$115.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Amit Daryanani</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$100.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$113.00</td>
<td>$153.00</td>
</tr>
<tr>
<td>Asiya Merchant</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$90.00</td>
<td>$110.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to NetApp. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of NetApp compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of NetApp's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into NetApp's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/NTAP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on NetApp analyst ratings.</a>
<h2>Discovering NetApp: A Closer Look</h2>
NetApp Inc is a provider of enterprise data management and storage solutions. The company's segments include Hybrid Cloud and Public Cloud. It generates maximum revenue from the Hybrid Cloud segment. The Hybrid Cloud segment offers a portfolio of storage management and infrastructure solutions that help customers recast their traditional data centers with the power of cloud. This portfolio is designed to operate with public clouds to unlock the potential of hybrid, multi-cloud operations. Hybrid Cloud is composed of software, hardware, and related support, as well as professional and other services.
<h3>NetApp's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, NetApp showcased positive performance, achieving a revenue growth rate of 5.55% as of 30 April, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: NetApp's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 19.63%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 33.42%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.43%, the company showcases effective utilization of assets.
Debt Management: NetApp's debt-to-equity ratio surpasses industry norms, standing at 3.11. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NTAP

Deep Dive Into NetApp Stock: Analyst Perspectives (11 Ratings)

During the last three months, 9 analysts shared their evaluations of Immunocore Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>), revealing diverse outlooks from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $71.78, a high estimate of $100.00, and a low estimate of $33.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.22%. 
<img src="https://www.benzinga.com/files/images/story/2025/1748898033_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A clear picture of Immunocore Holdings's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Jeff Jones</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$86.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Jessica Fye</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$50.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Gil Blum</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$71.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Graig Suvannavejh</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$33.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Gil Blum</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$71.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Andrew Galler</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Immunocore Holdings. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Immunocore Holdings compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Immunocore Holdings's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Immunocore Holdings's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/IMCR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Immunocore Holdings analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Discovering Immunocore Holdings: A Closer Look</h2>
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
<h3>Unraveling the Financial Story of Immunocore Holdings</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Immunocore Holdings's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 33.16%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Immunocore Holdings's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.35% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Immunocore Holdings's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.36%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Immunocore Holdings's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.49%, the company showcases efficient use of assets and strong financial health.
Debt Management: Immunocore Holdings's debt-to-equity ratio stands notably higher than the industry average, reaching 1.15. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IMCR

Demystifying Immunocore Holdings: Insights From 9 Analyst Reviews

Arvinas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) underwent analysis by 25 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">9</td>
<td align="right">6</td>
<td align="right">10</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $24.14, a high estimate of $81.00, and a low estimate of $8.00. Highlighting a 45.87% decrease, the current average has fallen from the previous average price target of $44.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1748898019_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Arvinas among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Berens</td>
<td>Leerink Partners</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$9.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Eliana Merle</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$21.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Terence Flynn</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$11.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Yigal Nochomovitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$9.50</td>
<td>$10.00</td>
</tr>
<tr>
<td>Srikripa Devarakonda</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$11.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Evan David Seigerman</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$10.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Derek Archila</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$19.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Paul Choi</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$8.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Michael Schmidt</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$16.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Edward Tenthoff</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$14.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Peter Lawson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Buy</td>
<td>$24.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Akash Tewari</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$10.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Paul Choi</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$12.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Joon Lee</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$21.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$81.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$81.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Terence Flynn</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$12.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Michael Schmidt</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$32.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Derek Archila</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$26.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Etzer Darout</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$20.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Robert Driscoll</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$12.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Tazeen Ahmad</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$28.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$81.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Yigal Nochomovitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$28.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Arvinas. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Arvinas compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Arvinas's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Arvinas's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ARVN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Arvinas analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Arvinas</h2>
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
<h3>Arvinas's Financial Performance</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Arvinas's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 646.25%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Arvinas's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 43.91% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Arvinas's ROE stands out, surpassing industry averages. With an impressive ROE of 13.57%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Arvinas's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.92% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.02, Arvinas adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARVN

What Analysts Are Saying About Arvinas Stock

In the current market session, Synovus Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>) stock price is at $47.36, after a 0.98% drop. However, over the past month, the company's stock went up by 6.09%, and in the past year, by 25.89%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1748898017_0.png" alt="Past Year Chart" />

<h3>How Does Synovus Financial P/E Compare to Other Companies?</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 12.59 in the Banks industry, Synovus Financial Inc. has a higher P/E ratio of 13.47. Shareholders might be inclined to think that Synovus Financial Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748898017_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: Synovus Financial

Equitable Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQH#NYSE">EQH</a>) has outperformed the market over the past 5 years by 5.72% on an annualized basis producing an average annual return of 18.89%. Currently, Equitable Holdings has a market capitalization of $16.14 billion. 
Buying $100 In EQH: If an investor had bought $100 of EQH stock 5 years ago, it would be worth $241.63 today based on a price of $52.70 for EQH at the time of writing.
<h3>Equitable Holdings's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748898014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Equitable Holdings Stock In The Last 5 Years

WIIM

MoonLake Immunotherapeutics shares are trading higher following reports that Merck held talks to acquire the Swiss biotech company for over $3 billion.

미국 달러의 추세는 강세를 보이고 있지만 Invesco DB US Dollar Index Bullish Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>)는 올해 들어 약 0.8% 하락했다.
여러 지표들이 달러가 단기적으로도 회복세를 유지할 수 있음을 시사하고 있으며, 이 추세로 혜택을 받을 수 있는 여러 <a href="https://www.benzinga.com/etfs">ETF</a>들이 있다:
<ul>
<li>WisdomTree Bloomberg U.S. Dollar Bullish Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USDU#NYSE">USDU</a>): 이 액티브 관리 ETF는 블룸버그 달러 총 수익 지수를 추적하며, 미국 달러에 직접적인 노출을 제공한다. 이 ETF는 국제 주식 및 채권과 강한 음의 상관관계를 가지므로, 글로벌 시장 불안정성에 대한 좋은 헤지 수단이 된다. 운용 수수료는 0.5%이다.</li>
</ul>
<ul>
<li>iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>): 강한 달러는 국내 중심의 소형주 기업들에게 유리하게 작용하는 경향이 있다. 이는 이들 기업들이 국제 무역으로 인한 환율 변동에 덜 영향을 받기 때문이다. 이 ETF는 러셀 2000 지수를 추적하고 운용 수수료는 0.19%이다.</li>
</ul>
<ul>
<li>iShares Currency Hedged MSCI EAFE ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/HEFA#BATS">HEFA</a>): 달러가 강세를 보일 때, 투자자들은 통화 헤지된 국제 펀드로 눈을 돌릴 수 있다. HEFA는 유럽, 아시아 태평양 및 동아시아의 선진 시장에 대한 노출을 제공하면서 환위험을 완화한다. 운용 수수료는 0.38%다.</li>
</ul>
<h3 class="wp-block-heading">달러에 영향을 미치는 시장 요인들</h3>
도널드 트럼프 대통령의 최신 관세 부과 조치는 글로벌 무역 긴장을 재점화시켜 일반적으로 달러에 긍정적인 영향을 미치는 시장 불확실성을 야기했다. 1월 30일, 트럼프는 멕시코와 캐나다에 25% 관세 부과(현재는 연기됨) 및 2월 4일 발효되는 모든 중국 수입품에 10% 관세 부과를 포함한 새로운 관세를 발표했다.
중국은 미국 상품에 대한 목표 관세를 부과하고 알파벳(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)과 같은 기업들에게 잠재적 제재에 대한 경고를 발했다. 캐나다도 미국에 대한 <a href="https://www.benzinga.com/markets/25/02/43423087/canada-retaliates-against-trumps-tariffs-with-countermeasures-25-tariffs-on-107-billion-of-us-made-goods">보복 관세를 부과</a>했다. 이러한 무역 정책에서 발생하는 불확실성은 투자자들이 안전 자산을 찾게 하여 달러에 대한 수요를 증가시키고 있다.
또한 읽기: <a href="https://kr.benzinga.com/news/usa/economy/%ED%8A%B8%EB%9F%BC%ED%94%84-%EC%9D%B4%EB%9E%80%EC%97%90-%EC%B5%9C%EB%8C%80-%EA%B2%BD%EC%A0%9C%EC%A0%81-%EC%95%95%EB%B0%95-%EC%A4%91%EA%B5%AD-%EA%B4%80%EC%84%B8-%EB%B3%B4%EB%B3%B5-%EA%B4%9C/" target="_blank" rel="noopener">트럼프, 이란에 대한 최대 경제적 압박 확인 및 중국의 관세 보복 &#8216;괜찮다&#8217; 발언</a>
연방준비제도는 1월 회의에서 금리를 4.25%–4.5%로 동결하며 인플레이션 우려가 남아 있는 상황에서 신중한 접근을 강조했다. 금리 인하에 대한 즉각적인 계획이 없고, 관세가 수입세로 작용하여 여전히 인플레이션 압력이 우려되는 가운데, 연준은 금리를 더 오랫동안 높게 유지할 수 있다. 덜 비둘기적인 연준은 일반적으로 달러에 긍정적이다. 높은 금리는 미국 자산을 외국 투자자들에게 더 매력적으로 만든다.
한편, 노동 시장 데이터는 경제가 안정적인 기반을 유지하고 있음을 시사한다. 1월의 <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43559446/us-economy-adds-fewer-than-expected-jobs-in-january-yet-unemployment-rate-slows-wage-growth-spikes">일자리 증가가 약간 둔화되었지만</a>, 4.0%의 실업률은 여전히 낮다.
임금 증가가 계속 강세를 보이면서 소비자 지출을 지원하고 연준이 2025년 6월 이전에 금리를 서둘러 인하하지 않을 것이라는 기대를 강화하고 있다.
제프리 로치(Jeffrey Roach), LPL 파이낸셜의 수석 이코노미스트가 비즈니스 스탠다드의 보도에서 언급했듯이, &#8220;<a href="https://www.benzinga.com/news/econ-s/25/02/43565669/january-jobs-report-not-too-hot-not-too-cold-leaves-interest-rate-cuts-unlikely-expert" target="_blank" rel="noopener" data-google-interstitial="false">4%의 실업률</a>은 매우 낮게 평가되며, 연준이 단기적으로 기준 금리를 변경하지 않을 이유를 제공한다.&#8221;
<h3 class="wp-block-heading">달러의 단기 전망</h3>
스테이트 스트리트 글로벌 어드바이저스(State Street Global Advisors)는 <a href="https://www.ssga.com/us/en/intermediary/insights/currency-commentary-january-2025">미국 달러가 2025년 1분기까지 강세를 유지할 것으로 예상</a>하며, 이는 강력한 성장, 상승하는 수익률 및 무역 긴장 속에서의 안전 자산으로서의 매력에 기인한다.
그러나 강력한 4분기 랠리 이후 롱 달러 포지션이 과열되면서, 차익 실현으로 인한 다음 1~2개월 동안의 약한 조정이 가능성 있다.
느린 입법 과정은 트럼프의 성장 긍정적인 정책에 대한 낙관론을 약화시킬 수 있지만, 중대한 경제 둔화가 발생하지 않는 한, 달러의 하락은 일시적이고 얕을 것으로 예상된다.

다음 읽기: 
<ul>
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/02/43560112/south-koreas-defense-sector-gets-a-us-gateway-with-kdef-etf">대한민국 방산 부문이 KDEF ETF를 통해 미국 시장에 진출</a></li>
</ul>
사진: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

2024년은 이정표를 세운 한 해였다. 현재의 강세장은 거의 <a href="https://www.benzinga.com/24/12/42430296/carson-researchs-50-year-study-suggests-that-the-26-months-old-bull-market-is-far-from-over">26개월이 지났지만</a> 흔들림 없는 상승세를 보이고 있다. 이는 2022년 10월 중순의 저점 대비 70% 이상 상승한 수치다. 한 해를 마무리하며 &#8216;산타 랠리&#8217;의 가능성을 염두에 두고 2024년의 중요한 시점을 정리해 보려고 한다.
<h3>미국 주요 벤치마크의 기록 경신</h3>
S&amp;P 500 지수는 올해 57번 사상 최고치를 경신했으며, 2024년 12월 6일에 마지막 최고치를 기록했다. 또한, 카슨 리서치의 수석 시장 전략가인 라이언 디트릭은 메모에서 "2024년은 역대 최고의 선거 연도 수익률로 기록될 것"이라고 말했다.
"50년 전으로 거슬러 올라가면 적어도 이만큼 오래 지속된 강세장은 5번 있었고, 그중 가장 짧게 지속된 강세장은 총 5년이었다. 유람선처럼 한 번 움직이기 시작하면 멈추기가 매우 어려울 수 있다.&#8221;
12월 23일 종가 기준으로 S&amp;P 500 지수는 연초 대비 25.96% 상승한 반면, SPDR S&amp;P 500 ETF Trust(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)는 같은 기간 25.82% 상승했다.
반면 다우존스 산업평균 지수는 올해 1,000포인트 돌파 기록을 8번이나 세웠다. 37,000선에서 출발해 12월 초에 45,000선을 돌파했다. 지수가 44,000포인트에서 45,000포인트까지 도달하는 데 단 7거래일밖에 걸리지 않았으며, 이는 역대 두 번째로 빠른 1,000포인트 돌파 기록이다. 그 후 지수는 1974년 이후 사상 최초로 최장 10일 연속 하락세를 기록하기도 했다.
12월 23일 종가 기준으로 다우존스 지수는 연초 대비 13.77% 상승한 반면, 같은 기간 SPDR 다우존스 산업평균 ETF Trust(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)는 13.74% 상승했다.
다우 지수와 달리 &#8216;매그니피센트 7&#8217; 종목이 모두 포함된 나스닥 100 지수는 12월 23일 종가 기준으로 연초 대비 29.98% 상승했다. 이 지수를 추종하는 ETF인 Fidelity NASDAQ Composite Index ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEQ#NASDAQ">ONEQ</a>)는 같은 기간 동안 33.85% 상승했다. 반면, Invesco QQQ Trust, Series 1(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)은 2024년 동안 29.88% 상승했다.
소형주 지수인 러셀 2000 지수는 1년 동안 11.16% 상승했고, 12월 23일 종가 기준으로 같은 기간 iShares Russell 2000 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>)는 10.97% 상승했다.
<img loading="lazy" decoding="async" class="alignnone size-medium" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/24021350/CHARt-1-INDICES-1024x576.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=2048" width="1024" height="576" />
<h3>세계를 압도하는 미국 시장</h3>
선진국 지수 중 S&amp;P 500 지수는 연초 대비 25.96% 상승하며 다른 모든 선진국 지수를 능가하는 최고의 지수로 남아 있다.
디트릭은 1897년 이후 새 대통령의 임기 <a href="https://x.com/RyanDetrick/status/1871317802306707882">첫해</a>에는 일반적으로 강세를 보였지만, 재임 첫해의 수익률은 전반적으로 좋지 않았다고 말했다.
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Returns during year one of a second term haven&#39;t been very good overall, but way better lately. 
Down 5 in a row, but now up 4 in a row. &#x1f914; <a href="https://t.co/aUrCbf22Gw">pic.twitter.com/aUrCbf22Gw</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1871320275129967103?ref_src=twsrc%5Etfw">December 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
<table class="block core-block table" style="height: 249px;" width="715">
<tbody>
<tr>
<td>선진국 시장</td>
<td>지수</td>
<td>2024년 성과 (2024년 12월 23일 종가 기준)</td>
</tr>
<tr>
<td>미국</td>
<td>S&amp;P 500</td>
<td>25.96%</td>
</tr>
<tr>
<td>독일</td>
<td>DAX</td>
<td>18.36%</td>
</tr>
<tr>
<td>일본</td>
<td>Nikkei 225</td>
<td>17.27%</td>
</tr>
<tr>
<td>홍콩</td>
<td>Hang Seng</td>
<td>19.71%</td>
</tr>
<tr>
<td>스페인</td>
<td>IBEX 35</td>
<td>12.31%</td>
</tr>
<tr>
<td>영국</td>
<td>FTSE 100</td>
<td>4.94%</td>
</tr>
<tr>
<td>스위스</td>
<td>Swiss Market</td>
<td>2.85%</td>
</tr>
<tr>
<td>프랑스</td>
<td>CAC 40</td>
<td>-3.43%</td>
</tr>
</tbody>
</table>
<h3>2024년 통신, 임의소비재 및 기술 섹터가 상승세 주도</h3>
미국 시장의 주요 섹터를 추종하는 상장지수펀드를 추적한 결과 통신 서비스가 올해 최고의 섹터로 부상했고, 임의소비재와 기술 섹터가 그 뒤를 이었다. 정보 기술 섹터는 S&amp;P 500에서 31.3%로 가장 높은 비중을 차지하고 있으며, 금융이 13.9%로 그 뒤를 잇고 있다.
블랙록은 2025년에도 기술 기업의 실적이 양호할 것으로 전망했다. "AI 테마와 수익 성장세가 확대됨에 따라 비중확대를 유지한다. AI 수혜주에 대한 밸류에이션은 기술 기업의 실적에 의해 뒷받침된다."
<table class="block core-block table" style="height: 403px;" width="832">
<tbody>
<tr>
<td>경기순환 섹터</td>
<td>ETF</td>
<td>2024년 성과 (12월 23일 종가 기준)</td>
</tr>
<tr>
<td>커뮤니케이션 서비스</td>
<td>Communication Services Select SPDR ETF (<a class="items-end ticker-link-wrapper inline-flex" style="font-family: inherit; font-size: inherit; font-weight: inherit;" href="https://www.benzinga.com/quote/xlc" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for XLC">XLC)</a>
<div class="ticker-wrapper">
<div class="sc-icgYrN hngKKh ticker-box-wrapper"></div>
</div>
</td>
<td>35.97%</td>
</tr>
<tr>
<td>임의소비재</td>
<td>Vanguard Consumer Discretionary ETF (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/vcr" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for VCR">VCR</a>)</td>
<td>27.21%</td>
</tr>
<tr>
<td>기술</td>
<td>Technology Select Sector SPDR ETF (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/xlk" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for XLK">XLK</a>)</td>
<td>27.01%</td>
</tr>
<tr>
<td>금융</td>
<td>Invesco S&amp;P 500 Equal Weight Financial ETF (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/rspf" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for RSPF">RSPF</a>)</td>
<td>23.48%</td>
</tr>
<tr>
<td>산업재</td>
<td>Vanguard Industrials ETF (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/vis" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for VIS">VIS</a>)</td>
<td>17.80%</td>
</tr>
<tr>
<td>부동산</td>
<td>Real Estate Select Sector SPDR (<a href="https://www.benzinga.com/quote/xlre" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for XLRE">XLRE</a>)</td>
<td>0.27%</td>
</tr>
<tr>
<td>소재</td>
<td>Materials Select Sector SPDR Fund (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/xlb" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for XLB">XLB</a>)</td>
<td>-0.37%</td>
</tr>
</tbody>
</table>
<img loading="lazy" decoding="async" class="alignnone size-medium" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/24021831/Chart-2.1-cyclical-sectors-1024x576.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=2048" width="1024" height="576" />
경기방어 섹터 중에서는 유틸리티 섹터가 승자로 부상한 반면 에너지가 저조한 성과를 보였다. S&amp;P 500 지수에서 필수소비재, 에너지, 유틸리티는 각각 5.7%, 3.4%, 2.5%의 비중을 차지한다.
모건스탠리에 따르면 에너지 섹터는 엇갈린 미래에 직면해 있다. 트럼프의 규제 완화는 전통적인 에너지에 도움이 될 수 있지만, 잠재적 공급 과잉과 특히 중국의 글로벌 수요 약세로 인해 석유에 대한 전망은 불확실하다.
반면 천연가스는 유럽의 강력한 수요와 전기화 및 AI 기반 데이터 센터에 대한 국내 사용 증가로 인해 성장할 수 있다. 트럼프가 바이든의 2022년 인플레이션 감축법 세액공제를 철회할 경우 청정 에너지 부문은 어려움에 직면할 수 있다. 그러나 공화당 주에 대한 혜택으로 인해 전면적인 폐지는 어려울 것으로 보인다.
<table class="block core-block table" style="height: 139px;" width="752">
<tbody>
<tr>
<td>경기방어 섹터</td>
<td>ETF</td>
<td>2024년 성과 (2024년 12월 23일 종가 기준)</td>
</tr>
<tr>
<td>유틸리티</td>
<td>Vanguard Utilities ETF (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/vpu" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for VPU">VPU</a>)</td>
<td>18.23%</td>
</tr>
<tr>
<td>필수소비재</td>
<td>Vanguard Consumer Staples ETF (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/vdc" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for VDC">VDC</a>)</td>
<td>10.04%</td>
</tr>
<tr>
<td>헬스케어</td>
<td>Vanguard Health Care ETF (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/vht" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for VHT">VHT</a>)</td>
<td>0.63%</td>
</tr>
<tr>
<td>에너지</td>
<td>The Energy Select Sector SPDR ETF (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/xle" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for XLE">XLE</a>)</td>
<td>-0.96%</td>
</tr>
</tbody>
</table>
<img loading="lazy" decoding="async" class="alignnone size-medium" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/24022041/Chart-2.2-defensive-sectors-1024x576.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=2048" width="1024" height="576" />
<h3>2024년 S&amp;P 500 최대 상승 기업</h3>
12월 23일 종가 기준으로 올해 S&amp;P 500 지수에서 386.67% 상승한 팔란티어는 올해 최고 수익률을 기록했다. 팔란티어의 뒤를 이어 비스트라와 엔비디아가 같은 기간 동안 각각 269.82%와 189.95%의 상승률을 기록했다.
<table class="block core-block table" style="height: 310px;" width="563">
<tbody>
<tr>
<td>S&amp;P 500 주식</td>
<td>2024년 성과 (2024년 12월 23일 종가 기준)</td>
</tr>
<tr>
<td>팔란티어 테크놀로지스 (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/pltr" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for PLTR">PLTR</a>)</td>
<td>386.67%</td>
</tr>
<tr>
<td>비스트라 (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/vst" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for VST">VST</a>)</td>
<td>269.82%</td>
</tr>
<tr>
<td>엔비디아 (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/nvda" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for NVDA">NVDA</a>)</td>
<td>189.95%</td>
</tr>
<tr>
<td>GE 버노바 (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/gev" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for GEV">GEV</a>)</td>
<td>162.80%</td>
</tr>
<tr>
<td>액손 엔터프라이즈 (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/axon" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for AXON">AXON</a>)</td>
<td>148.04%</td>
</tr>
<tr>
<td>유나이티드항공 (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/ual" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for UAL">UAL</a>)</td>
<td>144.30%</td>
</tr>
<tr>
<td>브로드컴 (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/avgo" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for AVGO">AVGO</a>)</td>
<td>114.07%</td>
</tr>
<tr>
<td>텍사스 퍼시픽 랜드 (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/tpl" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for TPL">TPL</a>)</td>
<td>113.03%</td>
</tr>
<tr>
<td>타르가 리소시스 (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/trgp" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for TRGP">TRGP</a>)</td>
<td>106.40%</td>
</tr>
<tr>
<td>하우멧 에어로스페이스 (<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/hwm" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for HWM">HWM</a>)</td>
<td>105.73%</td>
</tr>
</tbody>
</table>
<img loading="lazy" decoding="async" class="alignnone size-medium" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/24022228/Chart-3-top-performers-of-SPY-1024x576.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=2048" width="1024" height="576" />
<h3>2024년 미국 달러, 6% 이상 급등</h3>
달러 지수는 52주 100.1570~108.5410 범위에서 연초 대비 6.72% 상승했다. 달러가 이러한 상승세를 유지할 수 있다면 2015년 이후 두 번째로 좋은 한 해가 될 것이다.
쿠날 소다니 신한은행 글로벌 트레이딩 센터 부사장은 "트럼프의 정책 기대감과 연준의 금리 사이클에 대한 매파적 발언으로 인한 불확실성 때문에 달러 수요가 증가하고 있다"고 말했다.
프랭클린 템플턴은 "연준의 양적완화 사이클이 달러화의 지배적인 요인이 될 것이고, 금리 측면에서 연준과 주기적으로 비교하는 두 가지 주요 국가는 신흥시장과 일본&#8221;이라고 했다.
12월 23일 종가 기준 WisdomTree Bloomberg U.S. Dollar Bullish Fund(<a href="https://www.benzinga.com/quote/usdu">USDU</a>)는 연초 대비 13.24% 상승한 반면, Invesco DB USD Index Bullish Fund ETF(<a href="https://www.benzinga.com/quote/uup">UUP</a>)는 같은 기간 7.21% 상승했다.
<img loading="lazy" decoding="async" class="alignnone size-medium" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/24022447/Chart-4-Dollar-ETFs-1024x576.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=2048" width="1024" height="576" />
사진: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.
<div class="flex items-center gap-3 mt-1"></div>

2024년 S&P 500 지수는 57회 사상 최고치 경신, 나스닥 급등의 30%는 '매그 7' 그룹이 주도

목요일 미국 주식시장 뉴스 요약:
<ul class="block core-block">
<li>11월 21일 목요일, 미국 시장이 상승 마감했다. 다우지수가 461포인트 상승했으며, S&amp;P 500이 32포인트 추가 상승, 나스닥이 6포인트 소폭 상승했다. 세일즈포스는 견고한 실적으로 다우를 이끌었고, 엔비디아는 성장 전망이 완화되었음에도 불구하고 강력한 실적으로 상승했다. 반면, 알파벳은 법무부의 반독점 압박에 따른 급락을 경험했다.</li>
<li>경제 데이터에 따르면, 10월 미국 기존 주택 판매가 3.5% 증가하여 연환산 396만 채에 달했다. 필라델피아 연방은행 제조업 지수는 11월 -5.5로 하락하여 시장 예상치 8을 밑돌았다. 11월 16일로 끝나는 주의 신규 실업수당 청구 건수는 6,000건 감소하여 213,000건이었다.</li>
<li>대부분의 S&amp;P 500 섹터가 상승했으며, 유틸리티, 금융 및 소비재 섹터가 주도한 반면, 소비재 및 통신 서비스는 부진했다.</li>
<li>다우존스 산업평균지수가 1.06% 상승하여 43,870.35에 마감했으며, S&amp;P 500이 0.53% 상승하여 5,948.70, 나스닥 종합지수가 0.03% 상승하여 18,972.42로 마감했다.</li>
</ul>
아시아 시장 동향:
<ul class="block core-block">
<li>금요일, 일본의 닛케이 225 지수가 0.84% 상승하여 38,321.00으로 마감했다. 가스 및 수도, 운송 장비, 은행 섹터의 상승이 주도했다.</li>
<li>호주의 S&amp;P/ASX 200 지수가 0.85% 상승하여 8,393.80으로 마감했다. 에너지, 유틸리티, 헬스케어 섹터의 상승이 주도했다.</li>
<li>인도의 니프티(Nifty) 50 지수가 2.25% 상승하여 23,875.70으로 마감되었고, 니프티 500 지수가 1.79% 상승하여 22,210.40으로 마감되었다. 부동산, 기술, 공공 부문 기업들이 상승을 주도했다.</li>
<li>중국의 상하이 종합지수가 3.06% 하락하여 3,267.19로 마감되었고, 선전 CSI 300 지수가 3.10% 하락하여 3,865.70으로 마감되었다.</li>
<li>홍콩의 항셍지수가 1.89% 하락하여 19,229.97로 마감되었다.</li>
</ul>
유로존 시장 동향 (06:00 AM ET 기준):
<ul class="block core-block">
<li>유럽 STOXX 50 지수가 0.25% 하락했다.</li>
<li>독일 DAX 지수가 0.03% 하락했다.</li>
<li>프랑스 CAC 지수가 0.19% 하락했다.</li>
<li>FTSE 100 지수가 0.74% 상승했다.</li>
</ul>
원자재 시장 동향 (06:00 AM ET 기준):
<ul class="block core-block">
<li>WTI 원유가 배럴당 $70.14로 0.06% 상승 거래되고, 브렌트유가 배럴당 $74.27로 0.09% 상승 거래되고 있다.</li>
<li>이번 주 유가가 상승한 이유는 우크라이나 긴장이 고조되어 공급 차질 우려가 커진 데다 중국의 수입이 증가하는 조짐을 보였기 때문이다.</li>
<li>천연가스 가격이 0.45% 상승하여 $3.351로 거래되고 있다.</li>
<li>금 가격이 온스당 $2,672.45로 0.78% 상승 거래되고 있으며, 은 가격이 온스당 $31.115로 0.35% 상승했다. 반면, 구리 가격은 파운드당 0.83% 하락하여 $4.1210로 거래되고 있다.</li>
</ul>
미국 선물 시장 동향 (06:00 AM ET 기준):
다우 선물이 0.17% 하락, S&amp;P 500 선물이 0.28% 하락, 나스닥 100 선물이 0.40% 하락했다.
외환 시장 동향 (06:00 AM ET 기준):
미국 달러 지수가 0.33% 상승하여 107.32에 도달했으며, USD/JPY 환율이 0.08% 하락하여 154.39로, USD/AUD 환율이 0.17% 상승하여 1.5387로 거래되었다. 달러가 13개월 만에 최고치에 도달했다.
Image via Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

최근 러시아 카잔에서 열린 브릭스(BRICS) 정상 회의는 탈달러화에 대한 논의를 심화시켜 여러 주요 통화 중심 상장지수펀드(ETF)에 영향을 미칠 수 있으며, 미국 투자자들 사이에서 달러의 장기적인 <a href="https://www.benzinga.com/news/23/09/34269752/jp-morgan-warns-de-dollarization-can-make-us-lose-key-economic-crisis-tool">글로벌 무역 지배력</a>에 대한 우려를 불러일으켰다.
무슨 일이 (What Happened): 러시아 대통령 블라디미르 푸틴의 대안 국제 결제 시스템에 대한 추진은 확장된 브릭스 정상 회의에서 달러 표시 <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40293239/new-world-currency-not-so-fast-brics-nations-analyst-says-de-dollarization-is-a-myth" target="_blank" rel="noopener">자산에 대한 재조사</a>를 촉발했다.
압박을 받을 수 있는 주요 ETF로는 Invesco DB US Dollar Index Bullish Fund(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>)와 WisdomTree Bloomberg U.S. Dollar Bullish Fund(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USDU#NYSE">USDU</a>)가 있다.
푸틴은 정상 회의에서 &#8220;달러가 무기처럼 사용되고 있다. 우리는 이것이 사실임을 정말로 보고 있다. 이를 행하는 자들의 큰 실수라고 생각한다&#8221;고 말하며, 현재 러시아와 중국 간 무역의 거의 95%가 루블과 위안화로 이루어진다고 강조했다고, <a href="https://www.theguardian.com/world/2024/oct/23/putin-world-economy-bloc-brics-summit">가디언</a>이 보도했다.
시장 분석가들은 즉각적인 영향은 제한적일 수 있지만, 달러 기반 투자에 대한 장기적인 함의는 주목할 필요가 있다고 제안한다. Invesco DB USD Index Bearish ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UDN#NYSE">UDN</a>)는 투자자들이 잠재적인 통화 위험에 대비하면서 거래량이 증가했다.
참고: <a href="https://www.benzinga.com/news/24/10/41509995/kamala-harris-economic-policies-more-robust-more-sustainable-says-nobel-winning-economist-daren-acem">카멀라 해리스의 경제 정책은 &#8216;더 강력하고 더 지속 가능하다&#8217;고 노벨상 수상자 다렌 아세모글루가 말했다.</a>
그러나 통화 전문가들은 달러의 확고한 위치를 강조한다. 유럽 외교 관계 위원회의 제재 전문가인 아가트 드마레(Agathe Demarais)에 따르면, &#8220;전 세계 무역 거래의 80% 이상이 미국 달러로 청구되며, 이는 중앙은행 보유고의 거의 60%를 차지한다.&#8221;
왜 중요한가요 (Why It Matters): 이번 정상 회의의 결과는 러시아의 SWIFT 네트워크 우회 노력에도 불구하고 대안 결제 시스템에 대한 즉각적인 진전을 제한적으로 보이게 한다. 브릭스 내 반서구적 입장에 대한 브라질과 인도의 저항은 글로벌 금융 시스템의 대대적인 변화가 상당한 장애물에 직면했음을 나타낸다.
현재 터키, 인도네시아 및 나이지리아 등 12개의 신규 회원국을 포함하는 확장된 브릭스 블록은 달러 헤게모니에 대한 점점 더 큰 도전을 나타낸다. 그러나 시장의 기본 요인은 달러에서 다른 통화로의 전환이 즉각적이기보다는 점진적일 것임을 시사한다.

다음 읽을 내용:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41507397/bitcoin-ethereum-dogecoin-sink-amid-stocks-decline-treasury-yields-climb-analyst-sees-prom">비트코인, 이더리움, 도지코인, 주식 하락 및 국채 수익률 상승으로 하락: 분석가는 &#8216;유망한 신호&#8217;를 보고 있으며, &#8216;킹 크립토가 이 수준 이상을 유지하면 재테스트가 성공적&#8217;이라고 말한다.</a></li>
</ul>
이미지 출처: Unsplash
면책 조항:이 콘텐츠는 AI 도구의 도움을 받아 부분적으로 생성되었으며, Benzinga 편집자에 의해 검토 및 게시되었습니다.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요

Global

Economics

2024 브릭스 정상회의: 러시아 대통령 달러화 탈피를 촉구, 미국 투자자에 미치는 영향

투자 세계에서 미국 달러의 글로벌 금융 지배력이 약화되는 것에 대한 논란이 많다. 그러나 JP모건의 글로벌 리서치 의장인 조이스 장(Joyce Chang)은 다양화 경향과 <a href="https://www.benzinga.com/markets/forex">대체 금융 시스템</a>이 증가하고 있음에도 불구하고 여전히 달러의 지배력이 깊이 뿌리내리고 있다고 주장한다.
"달러 지배력이 의미 있게 침식되려면 수십 년이 걸릴 것 같다"고 그녀가 말했다.
<h2 class="wp-block-heading">탈달러화 위험은 과장되어 있다</h2>
장에 따르면, &#8220;중국에서의 탈달러화는 과장된 것으로 보인다.&#8221;
그녀는 달러가 계속해서 글로벌 금융의 초석이 되고 있다고 말한다. 이는 깊고 유동적인 자본 시장, 강력한 법치, 자유 유동 교환 체제에 대한 약속과 같은 요소에 의해 뒷받침된다. 이러한 구조적 요소는 세계의 기축 통화로서 달러의 역할을 뒷받침하여 달러의 지속적인 지배력을 보장한다.
현재 달러의 위치는 안전하지만 장은 국경 간 거래에서 중요한 변화를 강조한다. 러시아와 중국의 위안화 강세 추진에 대한 제재로 인해 특히 원자재 시장에서 달러화의 다변화가 더욱 심화되고 있다. 달러가 여전히 가장 널리 사용되는 통화임에도 불구하고 이러한 변화는 세계 무역과 금융 시스템을 재편하고 있다.
또한 읽어보세요: <a href="https://www.benzinga.com/markets/equities/24/08/40652826/dollar-surges-as-doubts-over-aggressive-rate-cuts-grow-wall-street-climbs-on-consumer-strength-7">공격적인 금리 인하에 대한 의구심이 커지면서 달러가 급등하고, 소비자 강세로 월스트리트가 상승: 연준의 인플레이션 데이터에 대한 7개 ETF 반응</a>
<h2 class="wp-block-heading">결제 자율성: 달러 패권에 대한 저평가된 위험</h2>
장은 "기술에 의해 촉발된 결제 자율성을 추구하는 것이 아마도 USD 헤게모니에 대한 가장 과소평가된 위험일 것이다"고 지적한다.
디지털 결제 시스템과 대체 금융 구조의 출현은 국내 금융을 빠르게 변화시키고 있다.
지역 은행들과 규제 당국들은 점점 더 거버넌스를 통제하려고 노력하고 있으며, 이는 해외 네트워크를 통한 디지털 결제에 대한 국내 계획의 개발로 이어진다.
이러한 발전은 주변적인 것처럼 보일 수 있지만 시간이 지남에 따라 달러의 지배력이 점차 약화될 수 있는 증가 추세를 나타낸다. 장은 달러로부터의 더 큰 통제력과 독립성에 대한 욕구에 의해 촉진된 이러한 변화는 투자자들이 면밀히 모니터링해야 할 과소평가된 위험이라고 강조한다.
<h2 class="wp-block-heading">투자 요약</h2>
투자자들은 달러의 지속적인 강세를 계속 인식해야 하지만 장기적으로 글로벌 금융 시스템에 영향을 미칠 수 있는 새로운 추세에도 세심한 주의를 기울여야 한다.
특히 원자재 시장에서 달러화를 사용하지 않는 다각화와 대체 결제 시스템의 부상이 주목해야 할 핵심 주제이다. 달러의 소멸이 과장되었을 수도 있지만, 진화하는 글로벌 금융 환경에는 신중한 탐색이 필요하다.
실행 가능한 통찰력: Invesco DB US Dollar Index Bullish Fund(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), WisdomTree Bloomberg U.S. Dollar Bullish Fund(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USDU#NYSE">USDU</a>) 및 Invesco DB US Dollar Index Bearish Fund(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UDN#NYSE">UDN</a>)의 투자자들은 이러한 통찰력에 특별히 주의를 기울여야 한다.
투자자들은 통화 노출을 다각화하고 대체 금융 시스템의 발전을 모니터링하기를 원할 수 있다. 이러한 변화는 장기 투자 전략에 영향을 미칠 수 있기 때문이다.
이미지: Photo by Sharon McCutcheon on Unsplash
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

WisdomTree Bloomberg U.S. Dollar Bullish Fund

뉴스

에 대한 최신 뉴스 WisdomTree Bloomberg U.S. Dollar Bullish Fund (ARCA:USDU)

토요일, 2월 08, 2025

목요일, 12월 26, 2024

금요일, 11월 22, 2024

목요일, 10월 24, 2024

목요일, 9월 05, 2024

뉴스

파트너 / 기고자

벤징가 글로벌